INVESTIGATION ALERT: Berger Montague PC Investigates American Vanguard's Board Of Directors For Breach of Fiduciary Duties (NYSE: AVD)

Core Viewpoint - An investigation is underway regarding potential breaches of fiduciary duties by the Board of Directors of American Vanguard Corporation (AVD) in light of significant health risks associated with its subsidiary AMVAC Chemical Corporation's pesticide DCPA [1][4]. Group 1: Investigation Details - Berger Montague is advising AVD shareholders about the investigation into the Board of Directors for potential breaches of fiduciary duties [1]. - The investigation focuses on the failure to ensure product safety and the exposure of the company to significant litigation risks [4]. Group 2: Regulatory Actions - In August 2024, the U.S. Environmental Protection Agency (EPA) suspended all registrations of the pesticide DCPA manufactured by AMVAC due to significant health risks to unborn babies [2]. - This suspension marks the first use of the EPA's emergency suspension powers in 40 years, highlighting the urgency of the health risks posed by DCPA [2]. Group 3: Historical Context - The EPA had previously alerted AMVAC to potential health risks related to DCPA in 2013, but the company failed to provide necessary data for over ten years [3]. - AMVAC only submitted the required test results in November 2023, which confirmed the significant risks posed to pregnant mothers and their unborn children [3].